Distinguishing thrombotic thrombocytopenic purpura from primary immune thrombocytopenia accompanied by anemia using the carbon monoxide breath test

References

• Mariotte E, Azoulay E, Galicier L, et al. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. Lancet Haematol. 2016;3(5):e237–245. doi:10.1016/S2352-3026(16)30018-7
   PubMed Web of Science ®Google Scholar
• Reese JA, Muthurajah DS, Kremer Hovinga JA, et al. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer. 2013;60(10):1676–1682. doi:10.1002/pbc.24612
   PubMed Web of Science ®Google Scholar
• Staley EM, Cao W, Pham HP, et al. Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura. Haematologica. 2019;104(1):166–175. doi:10.3324/haematol.2018.198275
   PubMed Web of Science ®Google Scholar
• Sukumar S, Lämmle B, Cataland SR. Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management. J Clin Med. 2021;10(3). doi:10.3390/jcm10030536
   PubMed Web of Science ®Google Scholar
• Cohen CT, Zobeck M, Kim TO, et al. Adolescent acquired thrombotic thrombocytopenic purpura: An analysis of the pediatric health information system database. Thromb Res. 2023;222:63–67. doi:10.1016/j.thromres.2022.12.011
   PubMed Web of Science ®Google Scholar
• Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413(6855):488–494. doi:10.1038/35097008
   PubMed Web of Science ®Google Scholar
• Zheng XL, Vesely SK, Cataland SR, et al. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020;18(10):2486–2495. doi:10.1111/jth.15006
   PubMed Web of Science ®Google Scholar
• Caocci G, Mulas O, Mantovani D, et al. Safety and efficacy of caplacizumab retreatment in a real-life monocentric cohort of patients with immune-mediated thrombotic thrombocytopenic purpura. Thromb Res. 2023;228:189–190. doi:10.1016/j.thromres.2023.06.018
   PubMed Web of Science ®Google Scholar
• Page EE, Kremer Hovinga JA, Terrell DR, et al. Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015. Blood Adv. 2017;1(10):590–600. doi:10.1182/bloodadvances.2017005124
   PubMed Web of Science ®Google Scholar
• Soares Ferreira Junior A, Pinheiro Maux Lessa M, Boyle SH, et al. In patients with suspected immune TTP, admission source impacts hospital length of stay and time to therapeutic plasma exchange impacts clinical outcomes. Thromb Res. 2023;227:34–39. doi:10.1016/j.thromres.2023.05.001
   PubMed Web of Science ®Google Scholar
• Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780–3817. doi:10.1182/bloodadvances.2019000812
   PubMed Web of Science ®Google Scholar
• Bendapudi PK, Hurwitz S, Fry A, et al. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol. 2017;4(4):e157–e164. doi:10.1016/S2352-3026(17)30026-1
   PubMed Web of Science ®Google Scholar
• Domingo-González A, Regalado-Artamendi I, Martín-Rojas RM, et al. Application of the French TMA reference center score and the mortality in TTP score in de novo and relapsed episodes of acquired thrombotic thrombocytopenic purpura at a tertiary care facility in Spain. J Clin Apher. 2021;36(3):420–428. doi:10.1002/jca.21880
   PubMed Web of Science ®Google Scholar
• Fage N, Orvain C, Henry N, et al. Proteinuria increases the PLASMIC and French scores performance to predict thrombotic thrombocytopenic purpura in patients with thrombotic microangiopathy syndrome. Kidney Int Rep. 2022;7(2):221–231. doi:10.1016/j.ekir.2021.11.009
   PubMed Web of Science ®Google Scholar
• Saha M, McDaniel JK, Zheng XL. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics. J Thromb Haemost. 2017;15(10):1889–1900. doi:10.1111/jth.13764
   PubMed Web of Science ®Google Scholar
• Franco RS. Measurement of red cell lifespan and aging. Transfus Med Hemother. 2012;39(5):302–307. doi:10.1159/000342232
   PubMed Web of Science ®Google Scholar
• Coburn RF. The measurement of endogenous carbon monoxide production. J Appl Physiol. 2012;112(11):1949–1955. doi:10.1152/japplphysiol.00174.2012
   PubMed Web of Science ®Google Scholar
• Furne JK, Springfield JR, Ho SB, et al. Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. J Lab Clin Med. 2003;142(1):52–57. doi:10.1016/S0022-2143(03)00086-6
   PubMed Web of Science ®Google Scholar
• Zhang HD, Ma YJ, Liu QF, et al. Human erythrocyte lifespan measured by Levitt's CO breath test with newly developed automatic instrument. J Breath Res. 2018;12(3):036003. doi:10.1088/1752-7163/aaacf1
   PubMed Web of Science ®Google Scholar
• Shi Y, Li Y, Yang X, et al. Genotype-degree of hemolysis correlation in hereditary spherocytosis. BMC Genomics. 2023;24(1):304. doi:10.1186/s12864-023-09364-8
   PubMed Web of Science ®Google Scholar
• Mitlyng BL, Singh JA, Furne JK, et al. Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases. Am J Hematol. 2006;81(6):432–438. doi:10.1002/ajh.20644
   PubMed Web of Science ®Google Scholar
• Gao QY, Zhu YM, Hu J, et al. [Red blood cell lifespan detected by endogenous carbon monoxide breath test in patients with polycythemia vera]. Zhonghua Nei Ke Za Zhi. 2019;58(10):777–781.
   PubMedGoogle Scholar
• Wang Y, Zhang Z, Liu Y, et al. Use of carbon monoxide breath test to assess red blood cell lifespan in newly diagnosed multiple myeloma patients. J Breath Res. 2019;13(4):046008. doi:10.1088/1752-7163/ab2c12
   PubMed Web of Science ®Google Scholar
• Zhang Y, Qian Y, Song LX, et al. The use of carbon monoxide breath test to detect the effect of iron overload on erythrocyte lifespan in MDS. Front Oncol. 2022;12:1058482. doi:10.3389/fonc.2022.1058482
   PubMed Web of Science ®Google Scholar
• Lei MQ, Sun LF, Luo XS, et al. Distinguishing iron deficiency anemia from thalassemia by the red blood cell lifespan with a simple CO breath test: a pilot study. J Breath Res. 2019;13(2):026007. doi:10.1088/1752-7163/aafe4f
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Motta I. Anemia in clinical practice-definition and classification: does hemoglobin change with aging? Semin Hematol. 2015;52(4):261–269. doi:10.1053/j.seminhematol.2015.07.006
   PubMed Web of Science ®Google Scholar
• Dinant HJ, de Maat CE. Erythropoiesis and mean red-cell lifespan in normal subjects and in patients with the anaemia of active rheumatoid arthritis. Br J Haematol. 1978;39(3):437–444. doi:10.1111/j.1365-2141.1978.tb01114.x
   PubMed Web of Science ®Google Scholar
• Thomas MR, Scully M. How I treat microangiopathic hemolytic anemia in patients with cancer. Blood. 2021;137(10):1310–1317. doi:10.1182/blood.2019003810
   PubMed Web of Science ®Google Scholar
• Zheng XL, Vesely SK, Cataland SR, et al. ISTH guidelines for treatment of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020;18(10):2496–2502. doi:10.1111/jth.15010
   PubMed Web of Science ®Google Scholar
• Joly BS, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017;129(21):2836–2846. doi:10.1182/blood-2016-10-709857
   PubMed Web of Science ®Google Scholar